Drukker W, Schwarz A, Vanherweghem J L
Int J Artif Organs. 1986 Jul;9(4):219-46.
Addiction and abuse of antipyretic analgesics has been recognized early after the turn of this century. The incidence markedly increased and the syndrome spread over many countries in the first half of the 20th century. The syndrome and its pathology, consisting of renal papillary necrosis and tubulo-interstitial nephritis, was first described in the medical literature in the early 1950's in Switzerland by Spühler and Zollinger, who rightly suspected chronic analgesic (Saridon) intoxication as being the cause in their cases. Clinically the disease is characterized by slowly progressive renal failure with renal colics from passage of necrotic papillae. Death from uremia is common unless dialyzed. The disease has been particularly prevalent in certain areas of Australia, Belgium, Western Germany, in Switzerland and some other countries. The nephrotoxic agents are mixtures of salicylates (aspirin) with phenacetin or acetaminophen. The principal nephrotoxic compound is probably aspirin--the aminophenol derivatives increasing its nephrotoxicity. However, all these components alone may cause--exceptionally--the syndrome. Rarely some newer, nonsteroid analgesics (NSAID's) can also be nephrotoxic. Phenacetin has--in particular in compound mixtures--mood-altering (euphoric) properties, giving rise to craving, addiction and chronic abuse. Addiction has been greatly facilitated by the over-the-counter availability of these cheap analgesic mixtures. Mass addiction--and abuse--may occur in all kinds of communities, in factories or families because of the euphoric effect, taking away fatigue and weariness and increasing productivity. There is a relation between the per capita consumption of antipyretic analgesics and analgesic nephropathy in several countries and in certain districts. The pattern of sales and mass consumption (and the incidence of nephropathy) is substantially promoted by the local presence of production facilities, usually accompanied by vigorous sales and advertising policies. Individual addiction usually occurs in psychoneurotic females often with social and marital problems and mental instability, often with long histories of headaches, backpains, and other, often psychogenic disorders. Analgesic nephropathy is often complicated by anemia, peptic ulcer, premature aging and atherosclerosis and in 8-10% by uro-epithelial carcinoma (the so called analgesic syndrome). The diagnosis depends largely on the history of chronic abuse of analgesics, which is often doggedly denied, hampering the diagnosis.(ABSTRACT TRUNCATED AT 400 WORDS)
本世纪初过后不久,人们就认识到了对解热镇痛药的成瘾和滥用现象。在20世纪上半叶,其发病率显著上升,且这种综合征蔓延到了许多国家。该综合征及其病理表现,包括肾乳头坏死和肾小管间质性肾炎,最早于20世纪50年代初由瑞士的施普勒和佐林格在医学文献中进行了描述,他们恰当地怀疑慢性镇痛药(索米痛片)中毒是其病例的病因。临床上,该病的特征是肾功能衰竭进展缓慢,伴有坏死乳头通过引起的肾绞痛。除非进行透析,否则死于尿毒症很常见。这种疾病在澳大利亚、比利时、西德、瑞士和其他一些国家的某些地区尤为普遍。肾毒性药物是水杨酸盐(阿司匹林)与非那西丁或对乙酰氨基酚的混合物。主要的肾毒性化合物可能是阿司匹林——氨基酚衍生物会增加其肾毒性。然而,单独使用所有这些成分也可能极个别地导致这种综合征。很少有一些新型非甾体类镇痛药(NSAID)也可能具有肾毒性。非那西丁——尤其是在复方混合物中——具有改变情绪(欣快感)的特性,会导致渴望、成瘾和长期滥用。这些廉价镇痛药混合物在非处方可得,极大地助长了成瘾现象。由于其欣快效应,能消除疲劳和倦怠并提高生产力,在各类社区、工厂或家庭中都可能发生大规模成瘾和滥用现象。在一些国家和某些地区,人均解热镇痛药消费量与镇痛药性肾病之间存在关联。当地生产设施的存在,通常伴随着积极的销售和广告政策,极大地推动了销售和大规模消费模式(以及肾病的发病率)。个体成瘾通常发生在患有神经官能症的女性身上,她们往往存在社会和婚姻问题以及精神不稳定,常常有长期的头痛、背痛和其他往往是心因性的疾病史。镇痛药性肾病常伴有贫血、消化性溃疡、早衰和动脉粥样硬化,8%至10%的患者会并发尿路上皮癌(即所谓的镇痛综合征)。诊断很大程度上取决于慢性滥用镇痛药的病史,而患者往往坚决否认,这给诊断带来了阻碍。(摘要截选至400字)